Tag:
Catalyst Pharmaceutical
Latest Headlines
Latest Headlines
Catalyst Pharma shares collapse after addiction drug flops in PhIIb
Catalyst Pharmaceutical Partners ($CPRX) says that its cocaine addiction therapy flopped in a Phase IIb study, missing primary and secondary endpoints and triggering a collapse in its share price, which tumbled 65% on the news.
Catalyst shares skyrocket as it sticks with addiction drug
Catalyst Pharmaceutical Partners' ( CPRX ) badly battered shares skyrocketed 86 percent after the developer announced that a close analysis of data from a failed mid-stage clinical trial inspired the
Catalyst's cocaine addiction med fails mid-stage trial
Catalyst Pharmaceutical Partners says its lead drug candidate CPP-109, a treatment for cocaine addiction, failed to meet its primary endpoint in a mid-stage trial. Results from the trial did not show
